These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9079224)

  • 1. Interactions of TCDD with signal transduction and neoplastic development in c-myc transgenic and TGF-alpha transgenic mice.
    Schrenk D; Müller M; Merlino G; Thorgeirsson SS
    Arch Toxicol Suppl; 1997; 19():367-75. PubMed ID: 9079224
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
    Thorgeirsson SS; Santoni-Rugiu E; Davis CD; Snyderwine EG
    Arch Toxicol Suppl; 1997; 19():359-66. PubMed ID: 9079223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
    Sanders S; Thorgeirsson SS
    Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.
    Factor VM; Kiss A; Woitach JT; Wirth PJ; Thorgeirsson SS
    J Biol Chem; 1998 Jun; 273(25):15846-53. PubMed ID: 9624185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
    Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
    Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenobarbital promotes liver growth in c-myc/TGF-alpha transgenic mice by inducing hypertrophy and inhibiting apoptosis.
    Sanders S; Thorgeirsson SS
    Carcinogenesis; 1999 Jan; 20(1):41-9. PubMed ID: 9934848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF; Thorgeirsson SS
    Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression.
    Llorente-Izquierdo C; Mayoral R; Cucarella C; Grau C; Alvarez MS; Flores JM; García-Palencia P; Agra N; Castro-Sánchez L; Boscá L; Martín-Sanz P; Casado M
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():106-15. PubMed ID: 23579063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter.
    Conolly RB; Andersen ME
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):281-93. PubMed ID: 9344896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of c-src knockout mice for the identification of the main toxic signaling pathway of TCDD to induce wasting syndrome.
    Vogel CF; Zhao Y; Wong P; Young NF; Matsumura F
    J Biochem Mol Toxicol; 2003; 17(6):305-15. PubMed ID: 14708085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF + TGF-alpha knockout mice.
    Abbott BD; Buckalew AR; DeVito MJ; Ross D; Bryant PL; Schmid JE
    Toxicol Sci; 2003 Jan; 71(1):84-95. PubMed ID: 12520078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
    Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
    Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
    Ohgaki H; Sanderson ND; Ton P; Thorgeirsson SS
    Cancer Lett; 1996 Aug; 106(1):43-9. PubMed ID: 8827045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha.
    Bryant PL; Schmid JE; Fenton SE; Buckalew AR; Abbott BD
    Toxicol Sci; 2001 Jul; 62(1):103-14. PubMed ID: 11399798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer.
    Calvisi DF; Ladu S; Hironaka K; Factor VM; Thorgeirsson SS
    J Hepatol; 2004 Nov; 41(5):815-22. PubMed ID: 15519655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.